Screen stocks the Peter Lynch way
Lynch looked for fast-growing companies at a reasonable price — the GARP strategy. He favored companies he could understand, with strong earnings growth, manageable debt, and a PEG ratio below 1.5.
How this screen is built
Every result passes all filters
This screen applies all criteria simultaneously across 100,000+ stocks. Every result must pass all filters — not just one or two.
Invest in What You Understand
Lynch only bought businesses he could explain in two minutes. The screen avoids black-box sectors and focuses on companies with transparent, repeatable business models — the kind where you understand why they make money.
Earnings Growth Above 15%
Lynch wanted fast growers, not just cheap stocks. Strong revenue and earnings growth above 15% annually is required — these are businesses actually expanding, not just cheap on paper.
PEG Below 1.5 — Growth at a Reasonable Price
Lynch's signature ratio: divide P/E by the earnings growth rate. A PEG below 1.5 means you are not overpaying for growth. Below 1 is ideal — you are getting growth essentially for free.
Clean Balance Sheet
Lynch avoided debt-heavy companies. A low debt ratio ensures the business can fund its growth internally, without diluting shareholders or becoming vulnerable when markets turn.
What Swalex adds on top
Positive FCF yield as a cash flow reality check. Lynch said earnings are accounting — cash flow is truth. This filter confirms the growth is real, not manufactured through accounting choices.
Last screen results
What the Peter Lynch screen surfaced
Results based on latest available data. Run the live screen for current results.
| Ticker | Name | Country | Quality | Revenue Growth | PEGY | FCF Yield | Debt Ratio |
|---|---|---|---|---|---|---|---|
| CYL.AX | Catalyst Metals | Australia | 85% | 156% | 0.05 | 6% | 25% |
| GUBRA.CO | Gubra | Denmark | 93% | 64% | 0.001 | 36% | 13% |
| GRTHO.IS | Grainturk Holding | Turkey | 85% | 93% | 0.23 | 5% | 13% |
| 688578.SS | Shanghai Allist Pharma | China | 86% | 83% | 0.11 | 6% | 10% |
| NTGAZ.IS | Naturelgaz | Turkey | 89% | 80% | 1.27 | 5% | 27% |
| OBM.AX | Ora Banda Mining | Australia | 84% | 75% | 0.17 | 8% | 32% |
| CPRX | Catalyst Pharmaceuticals | USA | 89% | 62% | 0.70 | 6% | 12% |
| INSP | Inspire Medical Systems | USA | 84% | 60% | 0.08 | 8% | 13% |
| TEZOL.IS | Europap Tezol | Turkey | 83% | 59% | 0.44 | 11% | 21% |
| TRAN.BA | Transener | Argentina | 88% | 62% | 0.07 | 7% | 28% |
This screen is inspired by publicly known investment principles attributed to Peter Lynch. Not affiliated with or endorsed by Peter Lynch or Fidelity Investments. Not investment advice.